Erythromycin Ophthalmic Ointment for Neonatal Prophylaxis and Treatment
Apply a single dose of 0.5% erythromycin ophthalmic ointment (approximately 1 cm ribbon) to both lower conjunctival sacs of every newborn immediately after birth, regardless of vaginal or cesarean delivery. 1, 2, 3
Administration Protocol for Prophylaxis
- Instill the ointment as soon as possible after delivery, ideally in the delivery room. 4, 2
- Use single-use tubes or ampules rather than multi-use containers to minimize contamination risk. 1, 2
- Do not flush the ointment from the eye after instillation. 3
- If administration cannot occur immediately, establish a monitoring system to ensure no infant is missed. 1, 2
- This prophylaxis is mandated by law in most U.S. states. 4, 2
Efficacy and Limitations
Erythromycin effectively prevents gonococcal ophthalmia neonatorum but has uncertain efficacy against chlamydial conjunctivitis. 1, 2, 5
- The U.S. Preventive Services Task Force concludes with high certainty that universal erythromycin prophylaxis provides substantial net benefit for preventing gonococcal ophthalmia, which develops in approximately 28% of newborns delivered to mothers with gonorrhea. 4, 2
- Prophylaxis does NOT prevent chlamydial conjunctivitis or eliminate nasopharyngeal Chlamydia trachomatis colonization. 1, 2, 5
- Moderate-certainty evidence shows prophylaxis probably reduces conjunctivitis of any etiology (RR 0.65,95% CI 0.54-0.78). 6
- Maternal prenatal screening and treatment remain the most effective strategy for preventing neonatal chlamydial disease. 4, 5
Treatment of Established Chlamydial Conjunctivitis
For confirmed chlamydial ophthalmia neonatorum (infants ≤30 days), systemic therapy is mandatory—topical treatment alone is inadequate. 4, 1, 5
Recommended Systemic Regimen
- Oral erythromycin base or ethylsuccinate 50 mg/kg/day divided into four doses for 14 days. 4, 1, 5
- Alternative: Oral azithromycin suspension 20 mg/kg/day as a single daily dose for 3 days. 1
Follow-Up Considerations
- Treatment efficacy is approximately 80%; a second 14-day course may be required for non-responders. 4, 5
- Follow-up is mandatory because more than 50% of affected infants have concurrent nasopharyngeal or pulmonary infection requiring systemic coverage. 5
- Evaluate for chlamydial pneumonia, which presents with repetitive staccato cough, tachypnea, and bilateral diffuse infiltrates on chest radiograph. 4
Critical Safety Warning
Infants younger than 6 weeks receiving oral erythromycin must be monitored for signs of infantile hypertrophic pyloric stenosis. 5
Treatment of Gonococcal Ophthalmia
Erythromycin is ineffective for active gonococcal infection; ceftriaxone is the treatment of choice. 1, 5
- Administer ceftriaxone 25-50 mg/kg IV or IM as a single dose (maximum 125-250 mg). 1, 5
- Only parenteral cephalosporins are recommended for pediatric gonococcal infections. 4, 2
- All children with gonococcal infection should be evaluated for concurrent chlamydial infection and retested approximately 3 months after treatment. 1
Contraindications and Alternatives
- Bacitracin must not be used for neonatal prophylaxis because it lacks efficacy. 4, 2
- Tetracycline 1% ophthalmic ointment is no longer available in the United States. 4, 1, 2
- Silver nitrate 1% causes significantly more chemical conjunctivitis at 24 hours compared with erythromycin (P < 0.001) and has been largely abandoned. 1, 2
- Povidone-iodine 2.5% has been studied but is not FDA-approved for this indication in the United States. 4, 2
Management of Mothers and Partners
When neonatal chlamydial infection is diagnosed, evaluate and treat the mother and her sex partners. 4
Pregnant Women with Chlamydial Infection
- Preferred regimen: Azithromycin 1 g orally as a single dose OR amoxicillin 500 mg orally three times daily for 7 days. 1, 5
- Alternative: Erythromycin base 500 mg orally four times daily for 7 days. 4, 5
- Erythromycin estolate is contraindicated during pregnancy because of drug-related hepatotoxicity. 4, 5
- Doxycycline, quinolones, and tetracyclines are contraindicated during pregnancy. 1
- Test-of-cure: Repeat testing 3 weeks after therapy completion is advised due to suboptimal efficacy and adherence concerns. 5
Special Considerations
When chlamydial or gonococcal conjunctivitis is identified in preadolescent children, sexual abuse should be evaluated and documented with standard culture techniques. 5